Patents by Inventor Roland A. BREITENMOSER

Roland A. BREITENMOSER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for the synthesis of chiral kynurenine compounds
    Patent number: 10294502
    Abstract: Provided are methods for synthesizing compounds, including chiral kynurenine compounds. The methods are suitable for large-scale manufacture and produce the chiral kynurenines compounds in high chemical purity and high chiral purity.
    Type: Grant
    Filed: November 14, 2017
    Date of Patent: May 21, 2019
    Assignee: VISTAGEN THERAPEUTICS, INC.
    Inventors: Stefan Abele, Klaus Laue, Roland A. Breitenmoser
  • METHODS FOR THE SYNTHESIS OF CHIRAL KYNURENINE COMPOUNDS
    Publication number: 20180171372
    Abstract: Provided are methods for synthesizing compounds, including chiral kynurenine compounds. The methods are suitable for large-scale manufacture and produce the chiral kynurenines compounds in high chemical purity and high chiral purity.
    Type: Application
    Filed: November 14, 2017
    Publication date: June 21, 2018
    Applicant: VISTAGEN THERAPEUTICS, INC.
    Inventors: Stefan ABELE, Klaus LAUE, Roland A. BREITENMOSER
  • Methods for the synthesis of chiral kynurenine compounds
    Patent number: 9834801
    Abstract: Provided are methods for synthesizing compounds, including chiral kynurenine compounds. The methods are suitable for large-scale manufacture and produce the chiral kynurenines compounds in high chemical purity and high chiral purity.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: December 5, 2017
    Assignee: VISTAGEN THERAPEUTICS, INC.
    Inventors: Stefan Abele, Klaus Laue, Roland A. Breitenmoser
  • METHODS FOR THE SYNTHESIS OF CHIRAL KYNURENINE COMPOUNDS
    Publication number: 20160032334
    Abstract: Provided are methods for synthesizing compounds, including chiral kynurenine compounds. The methods are suitable for large-scale manufacture and produce the chiral kynurenines compounds in high chemical purity and high chiral purity.
    Type: Application
    Filed: March 14, 2014
    Publication date: February 4, 2016
    Inventors: Stefan ABELE, Klaus LAUE, Roland A. BREITENMOSER